ZYME
Zymeworks Inc. Common Stock
NASDAQ: ZYME · HEALTHCARE · BIOTECHNOLOGY
$27.83
-0.39% today
Updated 2026-04-29
Market cap
$2.07B
P/E ratio
—
P/S ratio
19.51x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$11 – $30
Volume
0.7M
Zymeworks Inc. Common Stock (ZYME) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.02M | $-22.17M | $-35.25M | $219000.00 | $24.18M | $-81.85M | $-151.40M | $-192.45M | $144.11M | $-118.30M | $-110.04M | $-33.01M |
| Capital expenditures | $281000.00 | $853000.00 | $5.46M | $3.12M | $3.42M | $13.88M | $6.26M | $13.29M | $13.13M | $4.08M | $3.07M | $1.52M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $574000.00 | $1.39M | $4.29M | $3.43M | $13.44M | $49.00M | $29.12M | $10.76M | $4.01M | $8.10M | $17.79M | $28.03M |
| Free cash flow | $-7.30M | $-23.02M | $-40.71M | $-2.90M | $20.76M | $-95.73M | $-157.67M | $-205.74M | $130.98M | $-122.38M | $-113.11M | $-34.53M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $598000.00 | $1.11M | — | — | $814.17M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $6.56M | $86.22M | $114.14M | $-39.84M | — | — | — | — |